We found that FNDC3B was the downstream target gene of miR-1225-5p, and based on the results of biological functional assays, overexpression of FNDC3B can reverse miR-1225-5p-mediated inhibition in glioblastoma. This evidence concerns the gene FNDC3B and glioblastoma.